LSB logo

LSB

Profile

Full Name

LakeShore Biopharma Co., Ltd

Ticker Symbol

LSB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

August 5, 2021

Indexes

Not included

Website

http://www.ysbiopharm.com

Employees

758

Key Details

Price

$1.52(-7.88%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$80.21M(-20.09% YoY)

Annual EPS

-$5.66(-27.32% YoY)

PE ratio

-

Next earnings date

Apr 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.52
LSB price is $1.52

30-Day Relative Volume

1.39
LSB 30-day relative volume is 1.39

Price Performance

Price Today change

-7.88%
LSB price is down -7.88% today

Price YTD change

-56.07%
LSB price is down -56.07% since January 1st

Price 1-year change

-82.2%
LSB price is down -82.2% year-on-year

Price 3-year change

-98.44%
LSB price is down -98.44% over the past 3 years

Price Range

Price All-time high

$130.00
LSB price is currently -98.83% below its historical high of $130.00

Price 3-year low

$0.35
LSB price is currently +334.29% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$29.00M
LSB market capitalization is $29.00 million

Market cap 3-year change

-
LSB market capitalization 3-year change is unknown

Market cap All-time high

$934.65M
LSB market capitalization is currently -96.90% below its historical high of $934.65 million

Market cap sector rank

31.09%
LSB market capitalization is higher than 31.09% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.3%
LSB shares outstanding is up +0.3% year-on-year

Shares Outstanding 3-Year Change

-
LSB shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.62
LSB beta is 0.62

200-day SMA

$3.54
LSB price is currently -57.00% below its 200-day simple moving average

50-day SMA

$2.22
LSB price is currently -31.47% below its 50-day simple moving average

RSI

34.24
LSB 14-day relative strength index is 34.24

Volume

1.39
LSB 30-day relative volume is 1.39

ATR

$0.26
LSB average true range is $0.26

10-day Historical Volatility

82.38%
LSB 10-day historical volatility is 82.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$80.21M
LSB annual revenue is $80.21 million

Revenue Analysts estimate

$791.01M
LSB annual revenue is currently -89.86% lower than the consensus analysts' forecast

Revenue 1-year change

-20.09%
LSB annual revenue is down -20.09% year-on-year

Revenue Sector rank

53.74%
LSB annual revenue is higher than 53.74% of companies in Healthcare sector

EPS

EPS

-$5.66
LSB annual earnings per share is -$5.66

EPS Analysts estimate

-$17.80
LSB annual earnings per share is currently -68.18% lower than the consensus analysts' forecast

EPS 1-year change

-27.32%
LSB annual earnings per share is down -27.32% year-on-year

EPS Sector rank

17.4%
LSB annual earnings per share is higher than 17.4% of companies in Healthcare sector

Profit

Gross profit

$63.74M
LSB annual gross profit is $63.74 million

Gross margin

79.48%
LSB annual gross profit margin is 79.48%

Operating profit

-$37.44M
LSB annual operating income is -$37.44 million

Operating margin

-46.69%
LSB annual operating profit margin is -46.69%

Net income

-$60.63M
LSB annual net profit is -$60.63 million

Net margin

-75.59%
LSB annual net profit margin is -75.59%

Expenses

Total expenses

$117.65M
LSB annual total expenses is $117.65 million

Operating expenses

$101.19M
LSB annual total operating expenses is $101.19 million

Cost of goods sold

$16.46M
LSB annual cost of goods sold is $16.46 million

Selling, general & administrative expenses

$59.88M
LSB annual SGA is $59.88 million

Depreciation and amortization

$5.90M
LSB annual depreciation & amortization is $5.90 million

Interest expense

$6.20M
LSB annual interest expense is $6.20 million

Income tax

-$3.04M
LSB annual income tax is -$3.04 million

EBIT & EBITDA

EBIT

-$57.47M
LSB annual earnings before interest & taxes is -$57.47 million

EBITDA

-$51.57M
LSB annual EBITDA is -$51.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$212.61M
LSB annual total assets is $212.61 million

Non current assets

$85.70M
LSB annual long term assets is $85.70 million

Current assets

$126.92M
LSB annual total current assets is $126.92 million

Cash and cash equivalents

$34.62M
LSB annual cash & cash equivalents is $34.62 million

Accounts receivable

$62.41M
LSB annual accounts receivable is $62.41 million

Inventory

$28.59M
LSB annual inventory is $28.59 million

Liabilities

Total liabilities

$130.38M
LSB annual total liabilities is $130.38 million

Long term liabilities

$17.65M
LSB annual total long term liabilities is $17.65 million

Current liabilities

$112.73M
LSB annual total current liabilities is $112.73 million

Accounts payable

$9.52M
LSB annual accounts payable is $9.52 million

Debt

Total debt

$59.65M
LSB annual total debt is $59.65 million

Total debt 1-year change

-17.68%
LSB annual total debt is down -17.68% year-on-year

Long term debt

$14.16M
LSB annual long term debt is $14.16 million

Short term debt

$45.49M
LSB annual short term debt is $45.49 million

Equity & Capital

Shareholders equity

$82.23M
LSB annual stockholders equity is $82.23 million

Book value

$82.23M
LSB annual book value is $82.23 million

Retained earnings

-$324.25M
LSB annual retained earnings is -$324.25 million

Working capital

$14.18M
LSB annual working capital is $14.18 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$41.29M
LSB annual cash flow from operations is -$41.29 million

Cash from operations 1-year change

-54.94%
LSB annual cash flow from operations is down -54.94% year-on-year

Cash from investing

-$6.19M
LSB annual cash flow from investing activities is -$6.19 million

Cash from investing 1-year change

+25.63%
LSB annual cash flow from investing activities is up +25.63% year-on-year

Cash from financing

$28.71M
LSB annual cash flow from financing activities is $28.71 million

Cash from financing 1-year change

-38.08%
LSB annual cash flow from financing activities is down -38.08% year-on-year

CAPEX

CAPEX

$6.19M
LSB annual capital expenditures is $6.19 million

CAPEX 1-year change

-25.72%
LSB annual capital expenditures is down -25.72% year-on-year

Free Cash Flow

Free cash flow

-$47.48M
LSB annual free cash flow is -$47.48 million

Free cash flow 1-year change

-35.73%
LSB annual free cash flow is down -35.73% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

79.48%
LSB annual gross profit margin is 79.48%

Operating margin

-46.69%
LSB annual operating profit margin is -46.69%

Net margin

-75.59%
LSB annual net profit margin is -75.59%

ROA & ROE

ROA

-26.22%
LSB annual return on assets is -26.22%

ROE

-64.47%
LSB annual return on equity is -64.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LSB price to earnings ratio value is unknown

PE ratio Sector rank

-
LSB price to earnings ratio is unknown

PB Ratio

PB ratio

0.34
LSB price to book ratio is 0.34

PB ratio Sector rank

25.1%
LSB price to book ratio is higher than 25.1% of companies in Healthcare sector

PS Ratio

PS ratio

-
LSB price to sales ratio value is unknown

PS ratio Sector rank

-
LSB price to sales ratio is unknown

Enterprise value

Enterprise value

$74.51M
LSB enterprise value is $74.51 million

Enterprise value Sector rank

46.24%
LSB enterprise value is higher than 46.24% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
LSB EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
LSB EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.13
LSB annual current ratio is 1.13

Quick ratio

0.87
LSB annual quick ratio is 0.87

Leverage

Debt to equity

0.71
LSB annual debt to equity ratio is 0.71

Interest coverage ratio

-9.26
LSB annual interest coverage ratio is -9.26

Risk & Stability

Piotroski F-Score

-
LSB piotroski f-score value is unknown

Altman Z-Score

-2.44
LSB altman z-score is -2.44

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Spectral AI (MDAI)
OS Therapies Incorporated (OSTX)
FEMY logo
Femasys (FEMY)
PIII logo
P3 Health Partners (PIII)
CASI logo
CASI Pharmaceuticals (CASI)
ESLA logo
Estrella Immunopharma (ESLA)
INKT logo
MiNK Therapeutics (INKT)
Cadrenal Therapeutics (CVKD)
BNR logo
Burning Rock Biotech Limited (BNR)
  • What is the ticker symbol for LakeShore Biopharma Co Ltd?
  • Does LakeShore Biopharma Co Ltd pay dividends?
  • What sector is LakeShore Biopharma Co Ltd in?
  • What industry is LakeShore Biopharma Co Ltd in?
  • What country is LakeShore Biopharma Co Ltd based in?
  • When did LakeShore Biopharma Co Ltd go public?
  • Is LakeShore Biopharma Co Ltd in the S&P 500?
  • Is LakeShore Biopharma Co Ltd in the NASDAQ 100?
  • Is LakeShore Biopharma Co Ltd in the Dow Jones?
  • When was LakeShore Biopharma Co Ltd's last earnings report?
  • When does LakeShore Biopharma Co Ltd report earnings?

What is the ticker symbol for LakeShore Biopharma Co Ltd?

The ticker symbol for LakeShore Biopharma Co Ltd is NASDAQ:LSB

Does LakeShore Biopharma Co Ltd pay dividends?

No, LakeShore Biopharma Co Ltd does not pay dividends

What sector is LakeShore Biopharma Co Ltd in?

LakeShore Biopharma Co Ltd is in the Healthcare sector

What industry is LakeShore Biopharma Co Ltd in?

LakeShore Biopharma Co Ltd is in the Biotechnology industry

What country is LakeShore Biopharma Co Ltd based in?

LakeShore Biopharma Co Ltd is headquartered in China

When did LakeShore Biopharma Co Ltd go public?

LakeShore Biopharma Co Ltd's initial public offering (IPO) was on August 5, 2021

Is LakeShore Biopharma Co Ltd in the S&P 500?

No, LakeShore Biopharma Co Ltd is not included in the S&P 500 index

Is LakeShore Biopharma Co Ltd in the NASDAQ 100?

No, LakeShore Biopharma Co Ltd is not included in the NASDAQ 100 index

Is LakeShore Biopharma Co Ltd in the Dow Jones?

No, LakeShore Biopharma Co Ltd is not included in the Dow Jones index

When was LakeShore Biopharma Co Ltd's last earnings report?

LakeShore Biopharma Co Ltd's most recent earnings report was on Dec 19, 2024

When does LakeShore Biopharma Co Ltd report earnings?

The next expected earnings date for LakeShore Biopharma Co Ltd is Apr 18, 2025
On this page